thiazolyl blue has been researched along with apigenin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Hong, H; Liu, GQ | 1 |
Almar, M; Crespo, I; García-Mediavilla, MV; González, P; González-Gallego, J; Sánchez-Campos, S; Tuñón, MJ | 1 |
Hu, R; Liu, J; Xie, J; Zhao, X; Zhou, HB | 1 |
3 other study(ies) available for thiazolyl blue and apigenin
Article | Year |
---|---|
Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by scutellarin.
Topics: Animals; Antioxidants; Apigenin; Apoptosis; Calcium; Cytoprotection; DNA, Neoplasm; Dose-Response Relationship, Drug; Flavonoids; Glucuronates; Hydrogen Peroxide; L-Lactate Dehydrogenase; Lipid Peroxidation; Membrane Potentials; Mitochondria; PC12 Cells; Rats; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles; Vitamin E | 2004 |
Differential effects of dietary flavonoids on reactive oxygen and nitrogen species generation and changes in antioxidant enzyme expression induced by proinflammatory cytokines in Chang Liver cells.
Topics: Antioxidants; Apigenin; Blotting, Western; Cell Survival; Cytokines; Flavonoids; Flavonols; Glutathione; Hepatocytes; Humans; Inflammation; Kaempferols; Liver; Oxidation-Reduction; Quercetin; Reactive Nitrogen Species; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Superoxide Dismutase; Tetrazolium Salts; Thiazoles | 2008 |
Apigenin suppresses proliferation, invasion, and epithelial-mesenchymal transition of cervical carcinoma cells by regulation of miR-152/BRD4 axis.
Topics: Apigenin; Carcinoma; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; MicroRNAs; Neoplasm Invasiveness; Nuclear Proteins; Tetrazolium Salts; Thiazoles; Transcription Factors; Uterine Cervical Neoplasms | 2021 |